{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-038614","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2024-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.630947+00:00","generated_at":"2026-06-04T05:30:26.243702+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Renalytix amends bond agreement with CVI, adds beneficial ownership cap and payment deferral rights","bullets":["Amendment with CVI Investments adds a 9.99% beneficial ownership limitation on bondholder's ordinary shares.","Removes daily cap on ADS sales; shortens market price observation periods to 5 and 3 days.","Majority bondholders (>50% principal) can defer the April 7, 2024 scheduled amortization payment.","Majority bondholders also gain right to accelerate deferred April 2024 payment and future scheduled payments."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-038614","json":"https://secwatch.observer/filing/0000950170-24-038614.json","markdown":"https://secwatch.observer/filing/0000950170-24-038614.md","text":"https://secwatch.observer/filing/0000950170-24-038614.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024038614/0000950170-24-038614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024038614/rnlx-20240328.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T05:30:26.243702+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f448a76ef650c58687d6514daebd079b84d59846","claim":"Renalytix plc amended Bond Agreement Amendment with CVI Investments, Inc. (effective 2024-03-28).","evidence_excerpt":"On March 28, 2024, Renalytix plc (the “ Company ”) entered into a second amendment and restatement agreement (“ Bond Agreement Amendment ”) with CVI Investments, Inc. (\" CVI \"), which amended the terms of the Company’s existing bond agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024038614/0000950170-24-038614-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"CVI Investments, Inc."},{"label":"Effective","value":"2024-03-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}